New insights on testicular cancer prevalence with novel diagnostic biomarkers and therapeutic approaches
Cancer Reports · 2024
DOI: 10.1002/cnr2.2052 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Reports, 2024. Verfasst von Kadry M Sadek und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Veterinary Medicine, Damanhour University, Abadiyyat Damanhur, Egypt. Hauptthemen laut MEDLINE: Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Witten-Herdecke Germany.
Abstract (Originalsprache)
Background
Testicular cancer (TC), comprising merely 1% of male neoplasms, holds the distinction of being the most commonly encountered neoplasm among young males. Recent findings Most cases of testicular neoplasms can be classified into two main groups, namely germ cell tumors representing approximately 95% of the cases, and sex cord‐stromal tumors accounting for about 5% of the cases. Moreover, its prevalence is on the rise across the globe. TC is a neoplastic condition characterized by a favorable prognosis. The advent of cisplatin‐based chemotherapeutic agents in the latter part of the 1970s has led to a significant enhancement in the 5‐year survival rate, which presently surpasses 95%. Given that TC is commonly detected before reaching the age of 40, it can be anticipated that these individuals will enjoy an additional 40–50 years of life following successful treatment. The potential causes of TC are multifactorial and related to different pathologies. Accurate identification is imperative to guarantee the utmost efficacious and suitable therapy. To a certain degree, this can be accomplished through the utilization of blood examinations for neoplastic indicators; nonetheless, an unequivocal diagnosis necessitates an evaluation of the histological composition of a specimen via a pathologist.
Conclusion
TC is multifactorial and has various pathologies, therefore this review aimed to revise the prenatal and postnatal causes as well as novel diagnostic biomarkers and the therapeutic strategies of TC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Veterinary Medicine, Damanhour University, Abadiyyat Damanhur, Egypt.
- Department of Histology, Faculty of Veterinary Medicine, Damanhour University, Abadiyyat Damanhur, Egypt.
- University Centre for Research and Development, Chandigarh University, Mohali, Punjab, India.
- Department of Research and Development, Funogen, Athens, Greece.
- Department of Research and Development, AFNP Med, Wien, Austria.
- Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, New South Wales, Australia.
ORCID-Profile: Athanasios Alexiou, Hebatallah M Saad, Gaber El-Saber Batiha
Förderung
- University of Witten-Herdecke Germany
Zitieren
APA
Sadek, K. M., AbdEllatief, H. Y., Mahmoud, S. F. E., Alexiou, A., Papadakis, M., Al-Hajeili, M., Saad, H. M., & Batiha, G. E. (2024). New insights on testicular cancer prevalence with novel diagnostic biomarkers and therapeutic approaches. Cancer Reports. https://doi.org/10.1002/cnr2.2052
Vancouver
Sadek KM, AbdEllatief HY, Mahmoud SFE, Alexiou A, Papadakis M, Al-Hajeili M, et al. New insights on testicular cancer prevalence with novel diagnostic biomarkers and therapeutic approaches. Cancer Reports. 2024. doi:10.1002/cnr2.2052
BibTeX
@article{Sadek2024,
author = {Sadek, Kadry M and AbdEllatief, Hazem Y and Mahmoud, Sahar F E and Alexiou, Athanasios and Papadakis, Marios and Al-Hajeili, Marwan and Saad, Hebatallah M and Batiha, Gaber El-Saber},
title = {New insights on testicular cancer prevalence with novel diagnostic biomarkers and therapeutic approaches},
journal = {Cancer Reports},
year = {2024},
doi = {10.1002/cnr2.2052}
}
EUVIMED